 February 2017 - Industrial biology: the technological, economic and societal issues of biotechnology
Issue editor: Françoise ROURE,
Conseil général de l’économie (CGE)
and
Jean-Luc PUJOL,
Haut Conseil des biotechnologies (HCB)
To read summaries, click on the article titles
Editorial: Carlos MOEDAS,
European Commissioner of Research and Development
Foreword: Jean-Luc PUJOL,
Haut Conseil des biotechnologies (HCB)
et
Françoise ROURE,
Conseil général de l’économie (CGE)
The scientific, technical and innovative potentials
The knowledge necessary for industrial biology
Pierre Monsan,
president of the Fédération Française de Biotechnologie & founding chairman of the board of administration of Toulouse White Biotechnology
Big data in oncology: From basic research to applications in behalf of patients
Emmanuel Barillot,
director of INSERM laboratory 900 (Curie Institute),
and
Philippe Hupé,
assistant director of the bioinformatics platform at Curie Institute
Advanced metrology’s contribution to the assessment of medical-biological tests and the improvement of their reliability
Vincent Delatour,
expert in biomarkers, Laboratoire National de Métrologie et d’Essais (LNE)
Standardizing engineering techniques in biomedical research: Centers of biological resources
Bruno Clément,
director of the INSERM laboratory Nutrition, Metabolism and Cancer in Rennes & scientific director of Infrastructure Nationale Biobanques;
Paul Hofman,
professor of pathology at the Nice CHU;
Mireille Desille,
engineer at CRB-Santé, Rennes CHU;
and
Georges Dagher,
research director at INSERM & coordinator of Infrastructure Nationale Biobanques
The contribution of bioengineering to innovative applications: Materials of biological origin
François Ténégal,
managing director of the Institut Français des Matériaux Agro-Sourcés (IFMAS);
and
Patricia Krawczak,
professor at Institut Mines-Télécom (Mines Douai) & general secretary of the IFMAS Steering Committee on Strategy
New plant-breeding techniques: A few words from the world’s fourth seed company (Limagrain) on innovation in agriculture
Jean-Christophe Gouache,
director of International Affairs at Limagrain
Personalized medicine: How far? A research challenge for the pharmaceutical industry and its partners
Marc Bonnefoi,
vice-president of R&D, Sanofi France
Hydrocarbons produced by industrial biology: Global Bioenergies’ background and prospects
Marc Delcourt,
managing director of Global Bioenergies;
and
Ronan Rocle,
business manager
Modeling biological systems: A way to produce several forms of innovation
François Iris,
scientific director, founder and chairman of BMSystems;
and
Manuel Gea,
managing director, vice-president R&D and co-founder of BMSystems
The economic surge
Understanding value chains in industrial biotechnology
Jim Philp,
conseiller Biotechnologies à DSTI/OCDE,
Alain Schieb,
président de BACKCASTING SAS et consultant auprès de l’OCDE,
and
Mohamed Majdi Chelly,
ingénieur d’études à ENGIE Cofely France
Industrial bioeconomics at the regional level: The biorefinery at Bazancourt-Pomacle, a springboard for a territorial strategy
Maryline Thénot,
professor, head of the Finance Department, chair of Industrial Bioeconomics at NEOMA Business School;
and
Honorine Katir,
research engineer, chair of Industrial Bioeconomics at NEOMA Business School
Intellectual property and the maturity of innovations in industrial biology
Nathalie Mantrand-Foussadier,
senior consultant on chemistry and biotechnology, Questel Consulting
The map of industrial biology in France: Medical biotechnology
Gaëtan Poncelin de Raucourt,
chief engineer from École des Mines, head of the Health Industry Bureau (Direction générale des Entreprises, Ministry of the Economy and Finance)
The value of education and an education in values: Industrial biotechnology
Vanessa Proux,
managing director, Pôle de Compétitivité Medicen Paris Region and chair of Commission Formation;
and
Fabien Milanovic,
PhD in sociology from René Descartes University
Role of Nutritional Therapy in Healthcare Innovation: The Need for Reshaping Regulatory Paradigms
Manfred Ruthsatz,
PhD, Nestlé Health Science, Global Head of Regulatory Advocacy
Including microbiota in corporate strategies for research and innovation: The lessons drawn from MetaGenoPolis, a preindustrial demonstration project
Joël Doré,
PhD, research director at INRA and scientific director at MetaGenoPolis;
and
David Petiteau,
in charge of developing research through partnerships on Microbiome Programs at INRA
Toward a responsible industrial biology: Ethical and societal questions and controversies
The scope and limits of new plant-breeding techniques
Nils Braun
in change of biosecurity and safety, Haut Conseil des biotechnologies (Paris)
Microorganisms in the soil: Biological tools for reaching the objectives of sustainable development
Jean-Marc Châtaigner,
managing director of IRD;
and
Robin Duponnois,
director of the Laboratory of Tropical & Mediterranean Symbioses
New biotechniques: Ethical questions and the socioeconomic consequences on agriculture and biodiversity
Guy Kastler,
Confédération paysanne, a founding member of the network Semences paysannes
The misuse and malicious uses of the new biotechnologies
BrigGen (ret’d) Ioannis (John) Galatas,
MD, MA, MC (Army), Manager, CBRN Knowledge Center @ International CBRNE Institute (BE)
Genome-editing: A breakthrough technology
Hervé Chneiweiss,
neurologist, chairman of the Ethics Committee at INSERM
Miscellany
Additive manufacturing: Where are we?
Pascal Morand,
president of the Fédération de la Couture, du Prêt-à-Porter, des Couturiers et des Créateurs de Mode, member of the Academy of Technologies;
Joël Rosenberg,
head of innovation (Direction de la Stratégie, Ministry of Defense);
and
Dominique Turcq,
founding president of Boostzone Institute
|
